Get started

Healthcare

$CODX can rise in the next daysContextual immersion trading strategy idea. Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. The share price rose after the company announced that it had entered into an agreement with Arches Research, a subsidiary of Polarity TE (NASDAQ:PTE), to expand Arches' use of Co-Diagnostics' Logix Smart COVID-19 test. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price in the next days. So I opened a long position again from $11,62; stop-loss — $10,80. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:CODXLong
by KozakHlib
$MASI can fall in the next daysContextual immersion trading strategy idea. Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price in the next days. So I opened a short position from $218,41; stop-loss — $221,56. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:MASIShort
by KozakHlib
2
Possible Head & Shoulders for APHA?A H&S pattern is clearly noticeable on the RSI & KST. On the KST the right shoulder is lower than the left, but on the price the right shoulder is higher than the left, not sure if that's considered a bearish divergence but if there's further downside action it would seem accurate. On the KST each shoulder & the head display a bearish cross where I have placed the red finger, this happens when the red line crosses over the green in a downward angle.
A
by ScotianBot
1
Buying opportunity in CVS after Walgreens earnings bombCVS is pulling back in sympathy with Walgreens after WBA earnings were a dud. However, the adverse impact on Walgreens sales was "almost entirely from the company's non-U.S. businesses," according to the company's report. CVS operates almost exclusively in the United States, with 9,750 US locations and just 150 internationally. This suggests that CVS should be relatively insulated from the fall-off in international demand that Walgreens saw. CVS is in almost every way a better company than Walgreens. It has better analyst ratings, better financial health, and a much better valuation in terms of PEG ratio. Its dividend yield and dividend growth are lower, but its growth plan has been more aggressive, with the rollout of HealthHub stores and telehealth services continuing on schedule amidst the pandemic. Walgreens has lagged behind CVS in its plans to add healthcare clinics to its retail stores. CVS's relationship with UPS may prove an additional tailwind amidst the pandemic. Walgreens partners with UPS's smaller competitor, FedEx.
NYSE:CVSLong
by ChristopherCarrollSmith
DVAX- Is Approaching A Critical Level: 50%/120% potential profitDVAX - Is Approaching A Critical Level: DVAX- Is Approaching A Critical Level: 50%/120% potential profit Here’s A Way to Play It. see chart info: DVAX Dynavax Technologies Corporation Healthcare | Biotechnology | USA NEWS for Dynavax Technologies Corporation : as of August 13, 2020 www.fool.com finance.yahoo.com DISCLAIMER: Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks and options may fluctuate, and, as a result, may lose more than their original investment. All trading strategies , CHART are used at your own risk. ...
NASDAQ:DVAXLong
by Voxeurh514
TOPGLOV 1/8/2020Riding on the healthcare demand theme, topglov's share price has risen significantly in the past few months. While many are doubting the sustainability of the valuation and the continuous rally, investors/operator interest in glove counters seemed to be unfazed, with new highs charted almost every week. Chart and indicator wise, it seems like topglove is consolidating and inching upwards with an oversold RSI in the 1 hour chart. Based on the indicator, it seems like its a good entry now. i am still optimistic about this counter and believe it may chart higher highs in the future because 1) Health care product demand continue to surge 2) Most 2nd and 3rd tier healthcare counters across the world just had a rally 3) Results are expected to be spectacular due to its sheer production capacity and product mix compared to others 4) Share Split proposal Hartalega QR will be out this week. If history will repeat itself, we will likely to see a sharp correction in the glove sector after the publication of Harta's quarterly report, just like the last one. This is only my observation, lets revisit next week and see if it happens. EP: RM24-RM25 TP: RM30-RM31 CL: RM22-RM23
MYX:TOPGLOVLong
by jasontkj
Recommend adding Cardinal Health to your watch list - $64 TargetThis is more of investment logic than trading logic. I was keeping an eye on Cardinal to see if this Inverted H&D would play out, and it did not. Will be watching to see where it finds support - I am expecting it will be off the 20dma. If we see a nice morning star, or bullish hammer I will be looking to build a long from that point. I am keeping an eye on the weekly TF, not the daily as the reason I want to be in CAH is for the cheap value and 3.55% Dividend. Market Cap 15.96B Income -4158M Sales 153.59B Book/sh 4.12 Forward P/E 9.90 (Very inexpensive) P/FCF 12.46 (Bullish) Debt/Eq 6.04 EPS this Y +308% Sales Q/Q +11.2% EPS Q/Q +20.3% Earnings Aug 6th Gross Margin +4.5% ROE -176.4% (Very bearish) Profit MArgin -2.7% Short Float 1.75% Long term Target will be $64
NYSE:CAH
by ZenMode
2
Biotech ETF Tests the 50-day SMABiotechnology has been one of the stronger sectors this year. It’s benefited from the combination of Covid treatment hopes (vaccines + therapeutics), and the macro backdrop (low rates/negative GDP). As we highlighted earlier in the month, the iShares Nasdaq Biotechnology Index ETF broke out to new highs in late June and has been holding its ground above those peaks. Today it chopped back down to test $135, which has emerged as support since our last post. (That $135 line is also near intraday peaks a few times in May.) The other big line is the 50-day simple moving average (SMA). IBB recently bounced there, and now prices are revisiting it. This idea isn’t super fancy, but these are classic patterns in a sector that could make sense fundamentally. Biotechs are a long-term secular growth story. Long-term trend followers may like the risk/reward near the confluence of these flat lines and the 50day SMA.
NASDAQ:IBBLong
by TradeStation
NOTION (0083) - Kajian Potensi TP (TF Weekly) 30/07/2020@09:45pmNOTION VTEC BERHAD (0083) Notion VTec Berhad is an investment holding company. The Company is engaged in providing management services, and provides a range of services from design to production, tooling development, quality assurance, surface coating and finishing, heat treatment, and shipping and logistics. Its segments include Manufacturing and Investing. The Manufacturing segment is engaged in manufacturing precision components and tools, including design, other related activities and incidental services. The Investing segment is engaged in investment holding and provision of management services. Its products include Data Storage, Digital Imaging and Industrial & Automotive. It supplies precision-turned, milled, drilled and ground parts to renowned multi-national companies all over the world. Its services include product development, tooling and fixtures development, process engineering, mechanical machining processes, surface treatment, precision washing technology and waste water treatment. SECTOR: TECHNOLOGY SUB-SECTOR: TECHNOLOGY EQUIPMENT TOTAL SHARE ISSUE: 504,975,973 PUBLIC FLOAT %: 50.73% BERITA TERBAHARU: Pada 9 April 2020, Notion VTec menyatakan kepada Bursa bahawa syarikat itu telah memutuskan untuk menceburkan diri dalam pengeluaran peralatan pelindung diri dan komponen ventilator perubatan berikutan pandemik Covid-19 yang melanda seluruh dunia. Lembaga Pengarah Notion VTec mengumumkan bahawa Notion Venture Sdn Bhd ("NVSB"), anak syarikat milik penuh Notion VTec, telah memperolehi Perakuan Pendaftaran bertarikh 27 Julai 2020 dari Registrar Corp yang mengesahkan bahawa NVSB telah berdaftar dengan U.S. Food and Drug Administration untuk Tahun Kewangan 2020 untuk topeng muka (kecuali alat pernafasan N95) untuk Orang Awam / Personel Penjagaan Kesihatan mengikut Panduan IIE. NVSB juga telah mengirimkan sampel alat pernafasan N95 ke makmal luaran yang diiktiraf dan hasilnya akan durujuk kepada National Institute for Occupational Safety and Health ("NIOSH") untuk kelulusan. Sekiranya kelulusan alat pernafasan N95 diperolehi dari NIOSH, Notion beranggapan bahawa eksport topeng muka akan menjadi perniagaan jangka panjang syarikat. Notion juga mengumumkan bahawa NVSB juga telah menghantar permohonan untuk mendapatkan sijil halal ke Jabatan Kemajuan Islam Malaysia ("JAKIM") dan saat ini sedang menunggu hasil permohonan tersebut. Setelah mendapat perakuan dari JAKIM, Syarikat kemudian akan mengeksport topeng muka ke negara-negara Islam tertentu. ANALISA TEKNIKAL: NOTION mengalami kejatuhan setelah melakukan corak DOUBLE TOP dan harga telah bertahan dan melantun pada EMA50 (TF Weekly) dan seterusnya melakukan reversal. Harga ditutup pada aras RM0.815 pada penutup minggu ini (30/07/2020 - Khamis). Hari Jumaat (31/07/2020) adalah cuti umum sempena Hari Raya Aidiladha. Harga perlu melalui paras halangan Fibonacci yang kuat iaitu 0.382 (RM0.850), 0.500 (RM0.925) dan 0.618 (RM1.00) jika ingin meneruskan kenaikan yang lebih tinggi. #feelfreetodisagree #notAbuycall #tradeatyourownrisk #TAYOR #BursaMalaysia
NLong
by yuzieyusoff2
$ALGN can rise in the next daysContextual immersion trading strategy idea. Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $299,35; stop-loss — $279,00. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:ALGNLong
by KozakHlib
$ACOR can rise in the next daysContextual immersion trading strategy idea. Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $0,86; stop-loss — $0,81. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
ALong
by KozakHlib
$PRPO can rise in the next daysContextual immersion trading strategy idea. Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services in the United States oncology market. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $1,51; stop-loss — $1,34. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:PRPOLong
by KozakHlib
2